Technical Articles

基于TR-FRET技术的CD40/CD40L信号通路在免疫治疗中的作用研究
Study on the Role of CD40/CD40L Signaling Pathway in Immunotherapy Based on TR-FRET Technology
发布时间 2026-04-09
CD40 is a member of the tumor necrosis factor receptor superfamily, a 48 kDa type I transmembrane protein widely expressed on immune cells, particularly B cells, dendritic cells, and monocytes, playing a crucial role in bridging innate and adaptive immunity.
View details
  • Immunity/Inflamma
  • TR-FRET Technology
  • CD40/CD40L
  • Immunotherapy
Total 1
  • 1
Go to